Wealth Enhancement Advisory Services’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.9M | Sell |
26,552
-1,382
| -5% | -$307K | 0.01% | 831 |
|
|
2025
Q1 | $6.25M | Sell |
27,934
-2,318
| -8% | -$519K | 0.01% | 741 |
|
|
2024
Q4 | $9.91M | Sell |
30,252
-1,375
| -4% | -$450K | 0.02% | 556 |
|
|
2024
Q3 | $9.49M | Sell |
31,627
-642
| -2% | -$193K | 0.02% | 529 |
|
|
2024
Q2 | $10.6M | Sell |
32,269
-4,493
| -12% | -$1.48M | 0.03% | 475 |
|
|
2024
Q1 | $14.5M | Sell |
36,762
-303
| -0.8% | -$120K | 0.04% | 381 |
|
|
2023
Q4 | $13.1M | Buy |
37,065
+105
| +0.3% | +$37K | 0.04% | 375 |
|
|
2023
Q3 | $13.9M | Buy |
+36,960
| New | +$13.9M | 0.05% | 342 |
|
|
2022
Q4 | – | Sell |
-6,378
| Closed | -$1.59M | – | 376 |
|
|
2022
Q3 | $1.59M | Buy |
6,378
+2,613
| +69% | +$653K | 0.02% | 190 |
|
|
2022
Q2 | $1.2M | Buy |
+3,765
| New | +$1.2M | 0.02% | 238 |
|
|
2021
Q3 | – | Sell |
-4,099
| Closed | -$1.53M | – | 346 |
|
|
2021
Q2 | $1.53M | Buy |
4,099
+514
| +14% | +$191K | 0.02% | 153 |
|
|
2021
Q1 | $1.04M | Buy |
3,585
+141
| +4% | +$41.1K | 0.02% | 194 |
|
|
2020
Q4 | $1.03M | Buy |
+3,444
| New | +$1.03M | 0.02% | 163 |
|
|
2020
Q3 | – | Sell |
-6,021
| Closed | -$1.54M | – | 247 |
|
|
2020
Q2 | $1.54M | Buy |
+6,021
| New | +$1.54M | 0.04% | 140 |
|